Bile salt metabolism is not the only factor contributing to Clostridioides (Clostridium) difficile disease severity in the murine model of disease

References

• Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008;70(4):298–304. doi:10.1016/j.jhin.2008.08.012.
   Google Scholar
• Farooq PD, Urrunaga NH, Tang DM, Von Rosenvinge EC. Pseudomembranous Colitis HHS public access. Dis Mon. 2015;61(5):181–206. doi:10.1016/j.disamonth.2015.01.006.
   Google Scholar
• McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97(7):1769–1775. doi:10.1111/j.1572-0241.2002.05839.x.
   Google Scholar
• Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012;18:21–27. doi:10.1111/1469-0691.12046.
   Google Scholar
• Viswanathan VK, Mallozzi MJ, Vedantam G. An overview of the disease and its pathogenesis, epidemiology and interventions Clostridium difficile infection. Gut Microbes. 2010;1(4):234–242. doi:10.4161/gmic.1.4.12706.
   Google Scholar
• Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008;197(3):435–438. doi:10.1086/525047.
   Google Scholar
• Becattini S, Taur Y, Pamer EG. Antibiotic-induced changes in the intestinal microbiota and disease [internet]. Trends in Molecular Medicine. 2016;22:458–478. doi:10.1016/j.molmed.2016.04.003.
   Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JFWM, Tijssen JGP, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–415. doi:10.1056/NEJMoa1205037.
   Google Scholar
• Fuentes S, Van Nood E, Tims S, Heikamp-De Jong I, Jf Ter Braak C, Keller JJ, Zoetendal EG, De Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. Isme J. 2014;8(10):1621–1633. doi:10.1038/ismej.2014.13.
   Google Scholar
• Petrof EO, Gloor GB, Vanner SJ, Weese SJ, Carter D, Daigneault MC, Brown EM, Schroeter K, Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome. 2013;1(1):3. doi:10.1186/2049-2618-1-3.
   Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2014;517(7533):205–208. doi:10.1038/nature13828.
   Google Scholar
• Khanna S, Pardi DS, Kelly CR, Kraft CS, Dhere T, Henn MR, Lombardo M-J, Vulic M, Ohsumi T, Winkler J, et al. A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection. J Infect Dis. 2016;214:173–181. doi:10.1093/infdis/jiv766.
   Google Scholar
• Ott SJ, Waetzig GH, Rehman A, Moltzau-Anderson J, Bharti R, Grasis JA, Cassidy L, Tholey A, Fickenscher H, Seegert D, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology. 2017;152:799–811. doi:10.1053/j.gastro.2016.11.010.
   Google Scholar
• Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EMM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil. 2013;25(1):4–15. doi:10.1111/nmo.12046.
   Google Scholar
• Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, et al. targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog. 2012;8(10):e1002995. doi:10.1371/journal.ppat.1002995.
   Google Scholar
• Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241–259. doi:10.1194/jlr.R500013-JLR200.
   Google Scholar
• Lewis BB, Buffie CG, Carter RA, Leiner I, Toussaint NC, Miller LC, Gobourne A, Ling L, Pamer EG. Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole. J Infect Dis. 2015;212(10):1656–1665. doi:10.1093/infdis/jiv256.
   Google Scholar
• Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, Bry L, Clish CB, Alm E, Korzenik JR. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016;43:1142–1153. doi:10.1111/apt.13616.
   Google Scholar
• Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol. 2008;190(7):2505–2512. doi:10.1128/JB.01765-07.
   Google Scholar
• Sorg JA, Sonenshein AL. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol. 2009;191(3):1115–1117. doi:10.1128/JB.01260-08.
   Google Scholar
• Francis MB, Allen CA, Sorg JA. Muricholic acids inhibit Clostridium difficile spore germination and growth. PLoS One. 2013;8(9):e73653. doi:10.1371/journal.pone.0073653.
   Google Scholar
• Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22–39. doi:10.1080/19490976.2015.1127483.
   Google Scholar
• Mallonee DH, Adams JL, Hylemon PB. The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase. J Bacteriol. 1992;174(7):2065–2071. doi:10.1128/jb.174.7.2065-2071.1992.
   Google Scholar
• Antunes LCM, Han J, Ferreira RBR, Lolić P, Borchers CH, Finlay BB. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother. 2011;55(4):1494–1503. doi:10.1128/AAC.01664-10.
   Google Scholar
• Theriot CM, Koenigsknecht MJ, Carlson PE, Hatton GE, Nelson AM, Li B, Huffnagle GB, Z Li J, Young VB. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014;5:3114. doi:10.1038/ncomms5972.
   Google Scholar
• Theriot CM, Bowman AA, Young VB. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere. 2015;1:e00045–15.
   Google Scholar
• Andréasson K, Norin KE, Midtvedt T. Influence of ampicillin, clindamycin or metronidazole upon the 7α-dehydroxylation of bile acids in the human intestine. Curr Microbiol. 1988;16(6):329–331. doi:10.1007/BF01568540.
   Google Scholar
• Theriot CM, Young VB. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection. Gut Microbes. 2014;5:86–95. doi:10.4161/gmic.27131.
   Google Scholar
• Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135(6):1984–1992. doi:10.1053/j.gastro.2008.09.002.
   Google Scholar
• Abhauer KP, Wemheuer B, Daniel R, Meinicke P. Tax4Fun: predicting functional profiles from metagenomic 16S rRNA data. Bioinformatics. 2015;31(17):2882–2884. doi:10.1093/bioinformatics/btv287.
   Google Scholar
• Yoon S, Yu J, McDowell A, Kim SH, You HJ, Ko GP. Bile salt hydrolase-mediated inhibitory effect of bacteroides ovatus on growth of Clostridium difficile. J Microbiol. 2017;55:892–899. doi:10.1007/s12275-017-7340-4.
   Google Scholar
• Thanissery R, Winston JA, Theriot CM. Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids HHS public access. Anaerobe. 2017;45:86–100. doi:10.1016/j.anaerobe.2017.03.004.
   Google Scholar
• Van Eldere J, Celis P, De Pauw G, Lesaffre E, Eyssen H. Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol. 1996;62:656–661.
   Google Scholar
• Gustafsson N, Norin E, Midvedt KI. Effect of clindamycin given alone or with Lactobacillus delbrueckii and Streptococcus thermophilus on 7a-dehydroxylation of bile acids in rats. Clin Microbiol Infect. 1998;4:594–598.
   Google Scholar
• Saiful Islam KBM, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. YGAST. 2011;141:1773–1781.
   Google Scholar
• Ridlon JM, Alves JM, Hylemon PB, Bajaj JS. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes. 2013;4:382–387. doi:10.4161/gmic.25723.
   Google Scholar
• Collins J, Auchtung JM, Schaefer L, Eaton KA, Britton RA. Humanized microbiota mice as a model of recurrent Clostridium difficile disease. Microbiome. 2015;3:35. doi:10.1186/s40168-015-0097-2.
   Google Scholar
• Tam J, Beilhartz GL, Auger A, Gupta P, Therien AG, Melnyk RA. Small molecule inhibitors of Clostridium difficile toxin b-induced cellular damage. Chem Biol. 2015;22(2):175–185. doi:10.1016/j.chembiol.2014.12.010.
   Google Scholar
• Peniche AG, Savidge TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis. 2013;26(5):447–453. doi:10.1097/01.qco.0000433318.82618.c6.
   Google Scholar
• Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes. 2011;2(3):145–158. doi:10.4161/gmic.2.3.16333.
   Google Scholar
• Martens EC, Roth R, Heuser JE, Gordon JI. Coordinate regulation of glycan degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont. J Biol Chem. 2009;284(27):18445–18457. doi:10.1074/jbc.M109.008094.
   Google Scholar
• Engevik MA, Yacyshyn MB, Engevik KA, Wang J, Darien B, Hassett DJ, Yacyshyn BR, Worrell RT. Human Clostridium difficile infection: altered mucus production and composition. Am J Physiol - Gastrointest Liver Physiol. 2015;308(6):G510–24. doi:10.1152/ajpgi.00091.2014.
   Google Scholar
• Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011;79(4):1536–1545. doi:10.1128/IAI.01104-10.
   Google Scholar
• Curtis MM, Hu Z, Klimko C, Narayanan S, Deberardinis R, Sperandio V. The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe. 2014;16(6):759–769. doi:10.1016/j.chom.2014.11.005.
   Google Scholar
• Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host Microbe. 2014;16(6):770–777. doi:10.1016/j.chom.2014.11.003.
   Google Scholar
• Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature. 2013;502:906–909. doi:10.1038/nature12503.
   Google Scholar
• Wrzosek L, Miquel S, Noordine M-L, Bouet S, Chevalier-Curt MJ, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. doi:10.1186/1741-7007-11-88.
   Google Scholar
• Jakobsson HE, Rodríguez-Piñeiro AM, Schütte A, Ermund A, Boysen P, Bemark M, Sommer F, Bäckhed F, Hansson GC, Johansson ME. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16(2):164–177. doi:10.15252/embr.201439263.
   Google Scholar
• Rea MC, Alemayehu D, Paul Ross R, Hill C. Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection. J Med Microbiol. 2013;62:1369–1378. doi:10.1099/jmm.0.058933-0.
   Google Scholar
• Schubert AM, Sinani H, Schloss PD. Antibiotic induced alterations of the murine gut microbiota and subsequent effects on colonisation resistance against Clostridium difficile. mBio. 2015;6:1–10. doi:10.1128/mBio.00974-15.
   Google Scholar
• Jenior ML, Leslie JL, Young VB, Schloss PD. Clostridium difficile alters the structure and metabolism of distinct cecal microbiomes during initial infection to promote sustained colonization. mSphere. 2018;23:e00261–18.
   Google Scholar
• Buckley AM, Spencer J, Candlish D, Irvine JJ, Douce GR. Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291. J. Med. Micro. 2011;60:1174–1180. doi:10.1099/jmm.0.028514-0.
   Google Scholar
• Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;3:4986–4988.
   Google Scholar
• Rose TM, Schultz ER, Henikoff JG, Pietrokovski S, McCallum CM, Henikoff S. Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences. Nucleic Acids Res. 1998;26(7):1628–1635. doi:10.1093/nar/26.7.1628.
   Google Scholar
• Mullish BH, Pechlivanis A, Barker GF, Thursz MR, Marchesi JR, McDonald JAK. Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease. Methods. 2018;149:49–58. doi:10.1016/j.ymeth.2018.04.028.
   Google Scholar
• Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19(5):455–477. doi:10.1089/cmb.2012.0021.
   Google Scholar
• Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–2069. doi:10.1093/bioinformatics/btu153.
   Google Scholar
• Want EJ, Coen M, Masson P, Keun HC, Pearce JT, Reily MD, Robertson DG, Rohde CM, Holmes E, Lindon JC, et al. Ultra-performance liquid chromatography-mass spectrometry profiling of bile acid metabolites in biofluids: application to experimental toxicology studies. Anal Chem. 2010;82:5282–5289. doi:10.1021/ac1007078.
   Google Scholar
• Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment,matching, and identification. Anal Chem. 2006;78:779–787. doi:10.1021/ac051437y.
   Google Scholar